Gorgas Gregory D. 4

Accession 0001640334-24-000332

CIK 0001621221other

View on SEC.gov Company Profile

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 7:10 PM ET

Size

29.1 KB

Accession

0001640334-24-000332

Insider Transaction Report

Form 4

Period: 2024-02-28

ARTELO BIOSCIENCES, INC.ARTL

Gorgas Gregory D.

DirectorPresident, CEO, CFO, Treasurer

Transactions

Award
Stock Option (right to buy)
2024-02-28+5,000→ 5,000 total
Exercise: $1.55Exp: 2029-08-29→ Common Stock (5,000 underlying)
Award
Stock Option (right to buy)
2024-02-28+55,634→ 55,634 total
Exercise: $1.55Exp: 2031-02-12→ Common Stock (55,634 underlying)
Award
Stock Option (right to buy)
2024-02-28+38,340→ 38,340 total
Exercise: $1.55Exp: 2031-03-05→ Common Stock (38,340 underlying)
Award
Stock Option (right to buy)
2024-02-28+90,334→ 90,334 total
Exercise: $1.55Exp: 2031-12-03→ Common Stock (90,334 underlying)
Award
Stock Option (right to buy)
2024-02-28+85,000→ 85,000 total
Exercise: $1.55Exp: 2033-02-01→ Common Stock (85,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−5,000→ 0 total
Exercise: $29.85From: 2023-08-29Exp: 2029-08-29→ Common Stock (5,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−55,634→ 0 total
Exercise: $39.90From: 2023-02-12Exp: 2031-02-12→ Common Stock (55,634 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−38,340→ 0 total
Exercise: $22.80Exp: 2031-03-05→ Common Stock (38,340 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−90,334→ 0 total
Exercise: $9.45Exp: 2031-12-03→ Common Stock (90,334 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−85,000→ 0 total
Exercise: $3.15Exp: 2033-02-01→ Common Stock (85,000 underlying)

Footnotes (9)

[F1]This option was granted on August 29, 2019 and was previously reported as covering 75,000 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F2]The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer).
[F3]This option was granted on February 12, 2021 and was previously reported as covering 834,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F4]This option was granted on March 5, 2021 and was previously reported as covering 575,100 shares at an exercise price of $1.52 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F5]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the "Plan")) through each such applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 5, 2021.
[F6]This option was granted on December 3, 2021 and was previously reported as covering 1,355,000 shares at an exercise price of $0.63 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F7]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 3, 2021.
[F8]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean February 1, 2023.
[F9]Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ARTELO BIOSCIENCES, INC.

CIK 0001621221

→

Entity typeother

Related Parties

filerCIK 0001526251

Filing Metadata

Form type: 4
Filed: Feb 29, 7:00 PM ET
Accepted: Mar 1, 7:10 PM ET
Size: 29.1 KB

View on SEC.gov